Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Akrevia Therapeutics
LabCentral 610, 610 Main Street
Cambridge, MA 02139
http://www.akrevia.com/

Akrevia Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's proprietary Aklusion platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of immune-activating proteins that can be safely delivered. Akrevia is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for patients living with cancer.

Key Contact
Name
Tim Clackson, Ph.D.
Title
President
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
09/27/18 $30,000,000 Series A Atlas Venture
F-Prime Capital Partners
undisclosed


Featured Reading